Characterization of novel anti-EGFR single domain antibodies and their application in active targeting of superparamagnetic iron oxide nanoparticles to glioblastoma
Glioblastoma multiforme is the most lethal primary brain tumor with a mean patient survival of 12 - 15 months. Efforts to treat glioblastoma with chemotherapeutics or radiation therapy have been largely ineffective, which is why the current treatment paradigm is predominantly based on surgery. Herei...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
McGill University
2012
|
| Subjects: | |
| Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=107747 |